Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/1998
08/13/1998WO1998034593A1 Method of treating dry eye disease with purinergic receptor agonists
08/13/1998WO1998030693A3 Tumor necrosis factor receptor 5
08/13/1998WO1998027959A3 New aqueous medicament preparations for the production of propellent gas-free aerosols
08/13/1998WO1998024888A3 Polypeptides encoded by a human lipase-like gene, compositions and methods
08/13/1998WO1998019670A3 Combination therapy of hepatitis C infections
08/13/1998WO1998004290A3 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
08/13/1998CA2625727A1 Methods for the administration of amifostine
08/13/1998CA2280518A1 Hiv integrase inhibitors
08/13/1998CA2280231A1 Member of the tnf family useful for treatment and diagnosis of disease
08/13/1998CA2280140A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
08/13/1998CA2279868A1 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
08/13/1998CA2279834A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms
08/13/1998CA2279531A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998CA2278854A1 Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin for treating type ii diabetes
08/13/1998CA2277544A1 Identification of inhibitors of protein tyrosine kinase 2
08/12/1998EP0857787A2 Histidine kinase from Staphylococcus aureaus
08/12/1998EP0857487A2 Combinations for prophylaxsis and/or treatment of benign prostatic hyperplasia containing a 17 beta-hydroxy steroid dehydrogenase (17bHSD) inhibitor and at least one further active ingredient
08/12/1998EP0857214A1 Novel saliva binding protein
08/12/1998EP0857061A1 Solubilisation methods
08/12/1998EP0857018A1 Betulinic acid derivatives and uses therefor
08/12/1998EP0825848A4 Novel collagen formulations
08/12/1998EP0625903B1 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
08/11/1998US5792833 Binds to human papilloma virus
08/11/1998US5792753 Topical anticarcinogenic agent
08/11/1998US5792752 Synergistic effect in cancer and leukemic cell growth inhibition when a site 1-selective compound is used in combination with a site 2-selective compound
08/11/1998US5792748 Method for inhibiting neoplastic disease in mammals
08/11/1998US5792648 Isolated, purified polynucleotide sequence encoding polypeptide having specified amino acid sequence
08/11/1998US5792452 Live salmonella vaccine having an increased stability
08/11/1998CA2090234C Method for providing improved analgesic effect
08/11/1998CA2064160C Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
08/07/1998CA2222984A1 Novel rat
08/07/1998CA2222957A1 Novel histidine kinase
08/06/1998WO1998033942A1 Diagnosis and treatment of myocardial failure
08/06/1998WO1998033925A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998WO1998033921A1 Novel human cystatin-like protein
08/06/1998WO1998033920A2 Tissue factor pathway inhibitor-3
08/06/1998WO1998033908A1 Human c5a-like receptor
08/06/1998WO1998033896A2 Microorganisms with increased production of clavulanic acid
08/06/1998WO1998033818A1 Human anion channel
08/06/1998WO1998033815A1 Amyloid beta protein (globular assembly and uses thereof)
08/06/1998WO1998033768A1 Arylsulfonylamino hydroxamic acid derivatives
08/06/1998WO1998033535A1 System, method and composition for dialysis and shock treatment
08/06/1998WO1998033513A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998WO1998033508A1 Calcareous material
08/06/1998WO1998033505A1 Antiviral agents
08/06/1998WO1998033494A1 Compositions and methods for prevention and treatment of vascular degenerative diseases
08/06/1998WO1998033491A2 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
08/06/1998WO1998033379A1 A novel method for treating epidermal or dermal conditions
08/06/1998WO1998027113A3 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
08/06/1998WO1998018440A3 Use of inhibitors of the activity of retinoic acid for treating sensitive skin
08/06/1998WO1998015275A3 Method and potentiated composition for treating migraine
08/06/1998WO1998010794A3 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
08/06/1998CA2280093A1 Compositions and methods for prevention and treatment of vascular degenerative diseases
08/06/1998CA2279991A1 Human anion channel
08/06/1998CA2279594A1 Calcareous material
08/06/1998CA2279490A1 Glutrnagln amidotransferase - a novel essential translational component
08/06/1998CA2279348A1 System, method and composition for dialysis and shock treatment
08/06/1998CA2279345A1 Tissue factor pathway inhibitor-3
08/06/1998CA2279344A1 Human c5a-like receptor
08/06/1998CA2279265A1 Novel human cystatin-like protein
08/06/1998CA2279214A1 Antiviral agents
08/06/1998CA2279207A1 Novel compounds
08/06/1998CA2278771A1 Soluble ctla4 mutant molecules and uses thereof
08/05/1998EP0856315A1 Medicinal composition
08/05/1998EP0856310A2 Method for stabilizing acriylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized acrylcarboxylic acid
08/05/1998EP0856157A1 Tumour-specific p450 protein
08/05/1998EP0856051A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
08/05/1998EP0856050A1 Transforming growth factor alpha hi
08/05/1998EP0856009A1 Cd6 ligand
08/05/1998EP0855915A2 Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases
08/05/1998EP0855910A1 Conjugates useful in the treatment of benign prostatic hyperplasia
08/05/1998EP0855908A1 Dietary regimen of nutritional supplements for relief of symptoms of arthritis
08/05/1998EP0831819A4 Method for inhibiting neoplastic disease in mammals
08/05/1998CA2221687A1 Tumor necrosis related receptor, tr5
08/04/1998US5789465 Collagen matrix
08/04/1998US5789447 Nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/04/1998US5789441 Leukotriene B4 as an antiviral and anti-neoplastic agent
08/04/1998US5789435 Topical application of carbonic anhydrase inhibitors
08/04/1998US5789397 Treating colon cancer
08/04/1998US5789387 Methods and compositions for treating fungal infections in mammals
08/04/1998US5789376 Transfusions with stabilized hemoglobin covalently bound to a nitroxide or polymers thereof
08/04/1998US5789200 Polypeptides and dna(rna) codes by genetic engineering for diagnosis and treatment of cancer, prostate, breast, lung or epithelial tumors
08/04/1998US5789000 Mixture with 2,2'-dithio-bis-ethane sulfonate
08/04/1998US5788987 Time-specific controlled release dosage formulation
08/04/1998US5788974 Drug regimen in labelled containers with charts indicating time of day and dosage; for ulcers caused by helicobacter.
08/04/1998US5788958 Using nitrous oxide synthase inhibitor
08/04/1998US5788952 Cosmetic and dermatological photoprotective formulations containing inorganic micropigments
08/04/1998CA2228536A1 Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
08/03/1998CA2220852A1 Tumor necrosis related receptor, tr4
07/1998
07/30/1998WO1998032865A1 Novel prostate-associated kallikrein
07/30/1998WO1998032854A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124
07/30/1998WO1998032851A1 Two human homologues of galectin-5
07/30/1998WO1998032850A1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
07/30/1998WO1998032460A1 Methods for diagnosing and treating body weight related disorders in animals
07/30/1998WO1998032447A1 Method of treating cancer using alkylglycerols in conjunction with chemotherapy
07/30/1998WO1998032444A1 USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION
07/30/1998WO1998032442A1 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids
07/30/1998WO1998032441A1 Use of central cannabinoid receptor antagonists for regulating appetence
07/30/1998WO1998032440A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator
07/30/1998WO1998032436A1 Treatment for premenstrual dysphoric disorder
1 ... 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 ... 1151